Overview
Background
Dr Brett Hughes graduated from the University of NSW with a Bachelor of Medical Science and Bachelor of Medicine and Surgery in 1997. He completed his postgraduate training in Canberra and Brisbane and was admitted as a Fellow of the Australian College of Physicians as a Specialist Medical Oncologist in 2005.
Dr Hughes is currently a Senior Staff Specialist Medical Oncologist at the RBWH and TPCH. He is also an Associate Professor at the University of Queensland since 2015. As the previous Clinical Director of Oncology (201-2017) and current Cancer Care Services Research lead at TPCH, Dr Hughes has established both an independent TPCH Oncology unit and continuing TPCH’s reputation as a lung cancer research centre of excellence.
Dr Hughes is an active senior member of the Thoracic Oncology Group Australasia (TOGA) and the Trans Tasman Radiation Oncology Group (TROG). He is also heavily involved in many pivotal multicentre trials of cancer therapy at both TPCH and RBWH with his principal research interests in Lung cancer, Head & Neck cancer, Mesothelioma, cutaneous SCC and Thyroid cancer. He has published over 100 peer review papers. Dr Hughes is also involved in undergraduate and post graduate teaching in his fields of research interest.
Availability
- Associate Professor Brett Hughes is:
- Available for supervision
Fields of research
Works
Search Professor Brett Hughes’s works on UQ eSpace
2012
Journal Article
Evaluation of circulating tumor cells and circulating tumor DNA in non-small cell lung cancer: Association with clinical endpoints in a phase II clinical trial of pertuzumab and erlotinib
Punnoose, Elizabeth A., Atwal, Siminder, Liu, Weiqun, Raja, Rajiv, Fine, Bernard M., Hughes, Brett G. M., Hicks, Rodney J., Hampton, Garret M., Amler, Lukas C., Pirzkall, Andrea and Lackner, Mark R. (2012). Evaluation of circulating tumor cells and circulating tumor DNA in non-small cell lung cancer: Association with clinical endpoints in a phase II clinical trial of pertuzumab and erlotinib. Clinical Cancer Research, 18 (8), 2391-2401. doi: 10.1158/1078-0432.CCR-11-3148
2012
Conference Publication
Safety of bevacizumab used in routine practice in patients with metastatic colorectal cancer
Dzienis, M., Malczewski, A., Goh, J., Hughes, B., Eastgate, M., Wyld, D. and Burge, M. (2012). Safety of bevacizumab used in routine practice in patients with metastatic colorectal cancer. Medical Oncology Group of Australia Incorporated Annual Scientific Meeting, Program and Abstracts: Targeting Cancer from Diagnosis to Cure & 5th Annual COGNO Annual Scientific Meeting, Brisbane, QLD Australia, 8-10 August 2012. Wiley-Blackwell Publishing.
2012
Journal Article
Quality-of-life among head and neck cancer survivors at one year after treatment: A systematic review
So, W. K. W., Chan, R. J., Chan, D. N. S., Hughes, B. G. M., Chair, S. Y., Choi, K. C. and Chan, C. W. H. (2012). Quality-of-life among head and neck cancer survivors at one year after treatment: A systematic review. European Journal of Cancer, 48 (15), 2391-2408. doi: 10.1016/j.ejca.2012.04.005
2011
Journal Article
Medical management of mesothelioma
Bowman, Rayleen, Relan, Vandana and Hughes, Brett (2011). Medical management of mesothelioma. Australian Prescriber, 34 (5), 144-147. doi: 10.18773/austprescr.2011.076
2011
Journal Article
Changes in 18F-fluorodeoxyglucose and 18F-fluorodeoxythymidine positron emission tomography imaging in patients with non-small cell lung cancer treated with erlotinib
Mileshkin, Linda, Hicks, Rodney J., Hughes, Brett G. M., Mitchell, Paul L. R., Charu, Veena, Gitlitz, Barbara J., Macfarlane, David, Solomon, Benjamin, Amler, Lukas C., Yu, Wei, Pirzkall, Andrea and Fine, Bernard M. (2011). Changes in 18F-fluorodeoxyglucose and 18F-fluorodeoxythymidine positron emission tomography imaging in patients with non-small cell lung cancer treated with erlotinib. Clinical Cancer Research, 17 (10), 3304-3315. doi: 10.1158/1078-0432.CCR-10-2763
2011
Journal Article
Clinicopathological report: Bilateral choroidal metastases from papillary thyroid cancer
Tran, Khoi, Bigby, Kieron J., Hughes, Brett G., Lee, Lawrence and Allison, Roger (2011). Clinicopathological report: Bilateral choroidal metastases from papillary thyroid cancer. Asia-Pacific Journal of Clinical Oncology, 7 (1), 11-14. doi: 10.1111/j.1743-7563.2010.01332.x
2011
Conference Publication
The lung cancer journey - a review from the prince charles hospital pulmonary malignancy unit
Rassam, L. J., Sinhal, N. P., Mackenzie, H., Bowman, R. V., Fong, K. M., Yang, I. A., Pratt, G., Fay, M., Hughes, B., Windsor, M. F. and Matar, K. (2011). The lung cancer journey - a review from the prince charles hospital pulmonary malignancy unit. 3rd Australian Lung Cancer Conference (ALCC), Melbourne VIC, Australia, 6-8 October 2011. Philadelphia PA, United States: Lippincott Willams & Wilkins. doi: 10.1097/01.JTO.0000394634.73009.dc
2011
Conference Publication
Challenging the distal-to-proximal technique in the administration of anti-cancer therapies: A prospective cohort study
Alexander, Alison, Chan, Raymond, Bransdon, Maree, Hughes, Brett, Brown, Leisa and Graham, Therese (2011). Challenging the distal-to-proximal technique in the administration of anti-cancer therapies: A prospective cohort study. The 20th annual RBWH Health Care Symposium: Personalised Health Care, Herston, Brisbane, QLD, Australia, 10-14 October 2011.
2010
Journal Article
Carboplatin and etoposide combined with bevacizumab for the treatment of recurrent glioblastoma multiforme
Francesconi, Alessandra B., Dupre, Simon, Matos, Marco, Martin, David, Hughes, Brett G., Wyld, David K. and Lickliter, Jason D. (2010). Carboplatin and etoposide combined with bevacizumab for the treatment of recurrent glioblastoma multiforme. Journal of Clinical Neuroscience, 17 (8), 970-974. doi: 10.1016/j.jocn.2009.12.009
2009
Journal Article
The segmental distribution and clinical significance of colorectal fluorodeoxyglucose uptake incidentally detected on PET-CT
Lee, Joseph C., Hartnett, Gemma F., Hughes, Brett G.M. and Ravi Kumar, Aravind S. (2009). The segmental distribution and clinical significance of colorectal fluorodeoxyglucose uptake incidentally detected on PET-CT. Nuclear Medicine Communications, 30 (5), 333-337. doi: 10.1097/MNM.0b013e32832999fa
2005
Journal Article
Life-threatening interaction between complementary medicines: Cyanide toxicity following ingestion of amygdalin and vitamin C
Bromley, Jonathan, Hughes, Brett G.M., Leong, David C.S. and Buckley, Nicholas A. (2005). Life-threatening interaction between complementary medicines: Cyanide toxicity following ingestion of amygdalin and vitamin C. Annals of Pharmacotherapy, 39 (9), 1566-1569. doi: 10.1345/aph.1E634
2005
Journal Article
Endovascular aneurysm repair versus open repair in patients with abdominal aortic aneurysm (EVAR trial 1): Randomized controlled trial
Greenhalgh, R. M., Brown, L. C., Epstein, D., Kwong, G. P.S., Powell, J. T., Sculpher, M. J., Thompson, S. G., Greenhalgh, R. M., Allison, D. J., Bell, P. R.F., Buxton, M. J., Harris, P. L., Hopkinson, B. R., Powell, J. T., Russell, I. T., Thompson, S. G., Brown, L. C., Barton, G., Epstein, D., Kwong, G. P.S., Macran, S., Manca, A., Reise, J. A., Williams, A., Greenhalgh, R. M., Beard, J. D., Buxton, M. J., Harris, P. L., Powell, J. T. ... Wilson, L. (2005). Endovascular aneurysm repair versus open repair in patients with abdominal aortic aneurysm (EVAR trial 1): Randomized controlled trial. The Lancet, 365 (9478), 2179-2186. doi: 10.1016/S0140-6736(05)66627-5
2005
Journal Article
Docetaxel-induced myositis: Report of a novel side-effect [1]
Hughes, B. G.M. and Stuart-Harris, R. (2005). Docetaxel-induced myositis: Report of a novel side-effect [1]. Internal Medicine Journal, 35 (6), 369-370. doi: 10.1111/j.1445-5994.2005.00846.x
2004
Journal Article
Cerebral relapse of metastatic gastrointestinal stromal tumor during treatment with imatinib mesylate: Case report
Hughes, Brett, Yip, Desmond, Goldstein, David, Waring, Paul, Beshay, Victoria and Chong, Guan (2004). Cerebral relapse of metastatic gastrointestinal stromal tumor during treatment with imatinib mesylate: Case report. BMC Cancer, 4 (1) 74. doi: 10.1186/1471-2407-4-74
Supervision
Availability
- Associate Professor Brett Hughes is:
- Available for supervision
Before you email them, read our advice on how to contact a supervisor.
Supervision history
Current supervision
-
Doctor Philosophy
The changing face of head and neck cancer: addressing and advancing best-practice nutritional care to improve outcomes for patients with human papillomavirus-associated disease
Associate Advisor
-
Doctor Philosophy
Developing predictive biomarkers for immunotherapy using deep spatial profiling
Associate Advisor
Other advisors: Associate Professor Arutha Kulasinghe
Completed supervision
-
2025
Doctor Philosophy
The investigation of the tumour microenvironment in head and neck squamous cell carcinoma to identify predictive biomarkers of response to immunotherapy
Associate Advisor
Other advisors: Dr Quan Nguyen, Associate Professor Arutha Kulasinghe
Media
Enquiries
For media enquiries about Associate Professor Brett Hughes's areas of expertise, story ideas and help finding experts, contact our Media team: